Heparin pretreatment does not alter heparin requirements during cardiopulmonary bypass

British Journal of Anaesthesia

Volumn 87, Issue 6, 2001, Pages 844-847

  Nicholson, S C ^a   Keeling, D M ^b   Sinclair, M E ^a   Evans, R D ^a  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^b CHURCHILL HOSPITAL   (United Kingdom)

Author keywords

Blood, anticoagulants, heparin; Blood, antithrombin; Surgery, cardiovascular

Indexed keywords

ANTITHROMBIN III; D DIMER; ETOMIDATE; FENTANYL; HEPARIN; PANCURONIUM; PROTHROMBIN; THIOPENTAL; THROMBIN ANTITHROMBIN COMPLEX;

ADULT; AGED; ANTICOAGULATION; ARTICLE; BLOOD CLOTTING TIME; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG MONITORING; DRUG SAFETY; HUMAN; MEASUREMENT; PRIORITY JOURNAL;

EID: 0035194708     PISSN: 00070912     EISSN: None     Source Type: Journal    
DOI: 10.1093/bja/87.6.844     Document Type: Article

References (15)

1. Heparin therapy during extracorporeal circulation. I. Problems inherent in existing heparin protocols
2. Heparin resistance after preoperative heparin therapy or intraaortic balloon pumping
3. The influence of preoperative anticoagulation on heparin response during cardiopulmonary bypass
4. Antithrombin III in patients treated with subcutaneous or intravenous heparin
5. Anticoagulant effect of unfractionated heparin in antithrombin-depleted plasma in vitro
6. Heparin und Antiheparin im Kindesalter. 2. Mitteilung: Untersuchungen über die klinische Relevanz des Phänomens der Heparinresistenz
7. Heparin resistance prior to cardiopulmonary bypass
8. Heparin resistance during cardiopulmonary bypass. The role of heparin pretreatment
9. Heparin anticoagulation during cardiopulmonary bypass in an antithrombin-III deficient patient. Implications relative to the etiology of heparin rebound
10. Safety issues in heparin and protamine administration for extracorporeal circulation
11. Heparin dosing and monitoring for cardiopulmonary bypass. A comparison of techniques with measurement of subclinical plasma coagulation
12. Diminished anticoagulant response to heparin in patients undergoing coronary artery bypass grafting
13. Hemostasis changes during cardiopulmonary bypass surgery
14. Adequate anticoagulation during cardiopulmonary bypass determined by activated clotting time and the appearance of fibrin monomer
15. A review of the clinical indications for the plasma heparin assay